MEETING FDA GUIDELINES FOR ADDITIVE MANUFACTURING IN
LIFE SCIENCES

Life Sciences companies strive to improve patient outcomes by driving innovation, personalization and enhancing product quality. The Food & Drug Administration (FDA) encourages Life Sciences companies to use additive manufacturing to achieve these goals, yet there are many complex regulations for them to manage.

In a new report, Personalized 3D Printing in Life Sciences, Life Sciences industry analyst, Axendia, outlines:

• Applications for additive manufacturing in Life Sciences
• Unique performance considerations for additive manufacturing equipment in Life Sciences
• FDA guidelines for ‘document,’ ‘describe’ and ‘identify’ in Life Sciences manufacturing
• How RIZE’s innovative APD additive manufacturing system is key to Traceability, Control of Process Parameters and validated processes that Life Sciences manufacturers must maintain and control to meet FDA requirements.